Diakos CI - Search Results

1

Metastatic primary breast neuroendocrine neoplasms: a case series.

Batty K, Taylor AM, Bernard EJ, Diakos CI, Clarke SJ, Guminski A, Baron-Hay S, Boyle F, Pavlakis N, Chan DL. Batty K, et al. Among authors: diakos ci. Intern Med J. 2023 Oct;53(10):1813-1818. doi: 10.1111/imj.15961. Epub 2022 Oct 31. Intern Med J. 2023. PMID: 36314732

2

Structure, stability, and interconversion barriers of the rotamers of cis-[Pt(II)Cl(2)(quinoline)2] and cis-[Pt(II)Cl(2)(3-bromoquinoline)(quinoline)] from X-ray crystallography, NMR spectroscopy and molecular mechanics evidence.

Davies MS, Diakos CI, Messerle BA, Hambley TW. Davies MS, et al. Among authors: diakos ci. Inorg Chem. 2001 Jun 18;40(13):3048-54. doi: 10.1021/ic001278v. Inorg Chem. 2001. PMID: 11399172

3

Cancer-related inflammation and treatment effectiveness.

Diakos CI, Charles KA, McMillan DC, Clarke SJ. Diakos CI, et al. Lancet Oncol. 2014 Oct;15(11):e493-503. doi: 10.1016/S1470-2045(14)70263-3. Lancet Oncol. 2014. PMID: 25281468 Review.

4

Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing.

Selinger C, Cooper W, Lum T, McNeil C, Morey A, Waring P, Amanuel B, Millward M, Peverall J, Van Vliet C, Christie M, Tran Y, Diakos C, Pavlakis N, Gill AJ, O'Toole S. Selinger C, et al. Histopathology. 2015 Nov;67(5):654-63. doi: 10.1111/his.12708. Epub 2015 May 24. Histopathology. 2015. PMID: 25847523

5

The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.

Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, Clarke SJ. Chan JC, et al. Among authors: diakos ci. Ann Surg. 2017 Mar;265(3):539-546. doi: 10.1097/SLA.0000000000001743. Ann Surg. 2017. PMID: 27070934 Free PMC article.

6

A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement.

Chan JCY, Diakos CI, Chan DLH, Engel A, Pavlakis N, Gill A, Clarke SJ. Chan JCY, et al. Among authors: diakos ci. Ann Surg. 2018 Jun;267(6):1119-1125. doi: 10.1097/SLA.0000000000002251. Ann Surg. 2018. PMID: 28394869

7

Prognostic and predictive biomarkers in neuroendocrine tumours.

Chan DL, Clarke SJ, Diakos CI, Roach PJ, Bailey DL, Singh S, Pavlakis N. Chan DL, et al. Among authors: diakos ci. Crit Rev Oncol Hematol. 2017 May;113:268-282. doi: 10.1016/j.critrevonc.2017.03.017. Epub 2017 Mar 18. Crit Rev Oncol Hematol. 2017. PMID: 28427516 Review.

8

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.

Chan DL, Pavlakis N, Schembri GP, Bernard EJ, Hsiao E, Hayes A, Barnes T, Diakos C, Khasraw M, Samra J, Eslick E, Roach PJ, Engel A, Clarke SJ, Bailey DL. Chan DL, et al. Theranostics. 2017 Mar 1;7(5):1149-1158. doi: 10.7150/thno.18068. eCollection 2017. Theranostics. 2017. PMID: 28435454 Free PMC article.

9

Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre.

Itchins M, Arena J, Nahm CB, Rabindran J, Kim S, Gibbs E, Bergamin S, Chua TC, Gill AJ, Maher R, Diakos C, Wong M, Mittal A, Hruby G, Kneebone A, Pavlakis N, Samra J, Clarke S. Itchins M, et al. Eur J Surg Oncol. 2017 Sep;43(9):1711-1717. doi: 10.1016/j.ejso.2017.06.012. Epub 2017 Jun 28. Eur J Surg Oncol. 2017. PMID: 28688722

10

Shinko D, Diakos CI, Clarke SJ, Charles KA. Shinko D, et al. Among authors: diakos ci. Clin Pharmacol Ther. 2017 Oct;102(4):599-610. doi: 10.1002/cpt.789. Epub 2017 Aug 24. Clin Pharmacol Ther. 2017. PMID: 28699186 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page